About This Journal
Advances in Medical Ethics is an open access journal that operates with a double-blind peer review policy.
It publishes original contributions that have a high likelihood of shaping the application and direction of medical ethics. The journal’s content is of primary interest to medical ethicists and bioethicists and is of interest to clinicians, attorneys, and judges who are faced with ethical dilemmas in the course of professional practice.
The journal launched in October 2014. It does not have an impact factor yet and it is not indexed in PubMed/Medline at the moment. Indexing will be requested very soon.
Advances in Medical Ethics is indexed by Google Scholar.
Aims & Scope
Advances in Medical Ethics focuses on different areas, including conducting ethical medical research, conflicts of interest, end of life issues, ethical decision-making, euthanasia, genetic testing and advanced diagnostics, informed consent, medical and surgical practice principles, medical futility, organ and tissue donation, rationing, stem cell treatments, and vulnerable populations.
There is no submission/publication fee and all interested readers can freely access the journal content online without the need for a subscription.
All manuscripts submitted to Advances in Medical Ethics should adhere to Longdom Publishing's editorial policies and to Longdom Publishing's policies on conflict of interest, human and animal rights, and informed consent.
Submission of a manuscript to Advances in Medical Ethics implies that all authors have read and agreed to its content and that the manuscript conforms to the journal’s policies.
All articles published in Advances in Medical Ethics are ‘open access,’ meaning that they are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers.
Authors of articles published in Advances in Medical Ethics are the copyright holders of their articles. However, the ‘open access’ policy implies that authors grant to any third party the right to use, reproduce or disseminate the article, provided that no substantive errors are introduced in the process, proper attribution of authorship and correct citation details are given, and that the bibliographic details are not modified. If the article is reproduced or disseminated in part, it must be clearly indicated.
Peer review process
Advances in Medical Ethics operates using a double-blind peer review system, in which both authors and reviewers are anonymous.
Advances in Medical Ethics is supported by an expert Editorial Board. Manuscripts submitted to the journal are reviewed by at least two experts selected by the managing editor.
Peer reviewers will be asked to recommend whether a manuscript should be accepted, revised or rejected. They should also alert the editors of any issues relating to author misconduct, such as plagiarism and unethical behavior.
Reviewers are required to declare any competing interests.
More information about the peer review process can be found here.
Authors are charged per Original and Review article and per Editorial or Commentary accepted for publication to defray the costs of publication (information is sent with the author’s proof).
Authors of papers exceeding 5,000 words (750 words for Letters to the Editor and Commentaries) will be charged a minimum fee of per additional 1,000 words. The usual charge will also apply. Word count will be calculated by the editorial office, using the Microsoft Word tool. The main body of the text, acknowledgments, sources of funding, disclosures, references, figure legends and tables are included in the total word count.
There is no color charge.
A cost estimate will be provided for author’s approval by the journal publisher.
Authors also have to add Value-Added Tax (VAT, currently 21%). Institutions paying the fee on behalf of the author can in most cases have the VAT refunded, or by providing Advances in Medical Ethics with their VAT registration number (except UK), avoid paying VAT altogether.
There is no charge to authors from the following countries: Afghanistan, Albania, Algeria, Angola, Armenia, Azerbaijan, Bangladesh, Belarus, Belize, Benin, Bhutan, Bolivia, Bosnia-Herzegovina, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Cape Verde, Central African Republic, Chad, Colombia, Comoros, Congo, Costa Rica, Côte d’Ivoire, Cuba, Democratic Republic of Congo, Djibouti, Dominican Republic, East Timor, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Federated States of Micronesia, Fiji, Gambia, Georgia, Ghana, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Iraq, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Kosovo (Serbia and Montenegro), Kyrgyzstan, Lao People’s Democratic Republic, Latvia, Lesotho, Liberia, Lithuania, Madagascar, Malawi, Maldives, Mali, Marshall Islands, Mauritania, Mongolia, Morocco, Mozambique, Myanmar, Namibia, Nepal, Nicaragua, Niger, Nigeria, Panama, Papua New Guinea, Paraguay, Peru, Republic of Moldova, Romania, Rwanda, Saint Vincent and the Grenadines, Samoa (Western), Sao Tome and Principe, Senegal, Sierra Leone, Solomon Islands, Somalia, Sudan, Suriname, Swaziland, Syrian Arab Republic, Tajikistan, The Former Yugoslav Republic of Macedonia, Togo, Tokelau, Tonga, Tunisia, Turkmenistan, Tuvalu, Uganda, Ukraine, United Republic of Tanzania, Uzbekistan, Vanuatu, Vietnam, Wallis and Fortuna, West Bank and Gaza, Yemen, Zambia, and Zimbabwe.
All content information of an accepted paper is strictly confidential and cannot appear in the media (in print or electronic form) before its embargo date and time. Authors/researchers, their respective public relations representatives and funding sponsors may not distribute or promote their work to the media prior to embargo.
If an embargo break is the result of any action by an author/researcher, he/she risks withdrawal of publication of his/her manuscript. Violations of the embargo policy may also jeopardize future acceptance of manuscripts to be published in the journal.
Generally, embargoes on journal articles lift the day and the time the article is published.
Although the Editorial Office will endeavor to notify authors of the anticipated publication date/time, it will not be responsible for any consequences of early online posting with regard to the intellectual property rights. To safeguard their intellectual property, authors should ensure that appropriate reports of invention and patent applications have been filed before the manuscript is accepted.
Requests for permission to reproduce figures, tables or portions of articles originally published in Advances in Medical Ethics can be obtained via the Editorial Office.
Manuscripts submitted to Advances in Medical Ethics should conform to “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” except if indicated otherwise in the instructions to authors.
Manuscripts submitted to Advances in Medical Ethics should not contain material previously published in other publications, except as an abstract, and must not be currently under consideration for publication in another journal. Redundant publication is publication of a paper that overlaps substantially with one already published. When submitting a paper, authors should make a full statement to the editor about all submissions and previous reports that might be regarded as redundant publication of the same or similar work.
The authors should alert the editor if the work includes subjects about whom a previous report has been published. Copies of such material should be included with the submitted paper to help the editor decide how to handle the matter. If redundant publication is attempted without such notification, authors should expect editorial action to be taken; at the least, the manuscript will be rejected.
Authors and referees are asked to declare any competing interests.
Original Contributions submitted by the editor-in-chief and any of the associate editors are handled by a Consulting Editor or by another editor, who makes all decisions about the manuscript (including choice of referees and ultimate acceptance or rejection).
The entire process is handled confidentially.
All manuscripts submitted from the Editor's home institution are also handled entirely by a Consulting Editor or by another editor from a different institution. The Editor (in Chief) and/or Associate Editors may additionally, from time to time, refer a manuscript to a Consulting Editor to avoid a real or reasonably perceived conflict of interest.
Ethics and Consent
Advances in Medical Ethics considers research and publication misconduct to be a serious breach of ethics, and will take such actions as necessary to address such misconduct. Authors should refer to the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors for full information.
Statements, opinions and results of studies published in Advances in Medical Ethics are those of the authors and do not reflect the policy or position of the journal.
Advances in Medical Ethics provides no warranty as to the articles' accuracy or reliability.
Advances in Medical Ethics is pleased to announce that it has partnered with the CLOCKSS Archive and LOCKSS program to preserve its content in CLOCKSS's geographically and geopolitically distributed network of redundant archive nodes, located at 12 major research libraries around the world. This action provides for content to be freely available to everyone after a "trigger event" and ensures an author's work will be maximally accessible and useful over time. LOCKSS system has permission to collect, preserve, and serve this Archival Unit. CLOCKSS system has permission to ingest, preserve, and serve this Archival Unit.